These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33548957)

  • 1. [Predictive value of platelet aggregation rate in hemodynamically significant patent ductus arteriosus in preterm infants].
    Ren Y; Gao XY; Wang HY; Yang B; Zhao DD; Huang D; Su M; Li L
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):113-118. PubMed ID: 33548957
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of near-infrared spectroscopy in monitoring intestinal tissue oxygen saturation in preterm infants with hemodynamically significant patent ductus arteriosus: a prospective research.
    Huang XB; Zhong X; Liu T; Cheng GQ; Qiu HX
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Aug; 23(8):821-827. PubMed ID: 34511172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is high platelet distribution width in the first hours of life can predict hemodynamically significant patent ductus arteriosus in preterm newborns?
    Demirel G; Yılmaz A; Vatansever B; Tastekin A
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2049-2053. PubMed ID: 30318943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants].
    Lu D; Liu Y; Tong X
    Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):187-93. PubMed ID: 26165015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between platelet indices and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.
    Ding R; Zhang Q; Duan Y; Wang D; Sun Q; Shan R
    Eur J Pediatr; 2021 Mar; 180(3):699-708. PubMed ID: 32949292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus].
    Wu ZQ; Zhang Y; Zhou QQ; Liu Q; Cheng S; Xia SW
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):343-349. PubMed ID: 38660897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when?
    Liu Y; Huang ZL; Gong L; Zhang Z; Zhang SC; Zhou YX
    Clin Hemorheol Microcirc; 2020; 75(3):335-347. PubMed ID: 32280084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Useful Platelet Indices for the Diagnosis and Follow-Up of Patent Ductus Arteriosus.
    Guler Kazanci E; Buyuktiryaki M; Unsal H; Tayman C
    Am J Perinatol; 2019 Dec; 36(14):1521-1527. PubMed ID: 31087312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion Index-Bedside Diagnosis of Hemodynamically Significant Patent Ductus Arteriosus.
    Balla KC; John V; Rao Pn S; Varghese K
    J Trop Pediatr; 2016 Aug; 62(4):263-8. PubMed ID: 26966242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
    Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.
    Karabulut B; Arcagök BC; Simsek A
    Fetal Pediatr Pathol; 2021 Apr; 40(2):103-112. PubMed ID: 31707901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: Red cell distribution width-to-platelet ratio.
    Özer Bekmez B; Tayman C; Büyüktiryaki M; Çetinkaya AK; Çakır U; Derme T
    J Clin Lab Anal; 2018 Nov; 32(9):e22616. PubMed ID: 29978492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic parameters of patent ductus arteriosus in preterm infants.
    Khositseth A; Nuntnarumit P; Chongkongkiat P
    Indian Pediatr; 2011 Oct; 48(10):773-8. PubMed ID: 21555809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: Should we pay more attention?
    Dani C; Mosca F; Cresi F; Lago P; Lista G; Laforgia N; Del Vecchio A; Corvaglia L; Paolillo P; Trevisanuto D; Capasso L; Fanos V; Maffei G; Boni L
    Early Hum Dev; 2019 Aug; 135():16-22. PubMed ID: 31212222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fresh Frozen Plasma Transfusion: An Independent Risk Factor for Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants.
    Huang CP; Hung YL; Hsieh WS; Shen CM
    Am J Perinatol; 2022 Oct; 39(13):1426-1432. PubMed ID: 33486746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association between Hemodynamically Significant Patent Ductus Arteriosus and 25-Hydroxyvitamin D Levels in Preterm Infants ≤32 Weeks Gestational Age.
    Baldan E; Yarci E
    Fetal Pediatr Pathol; 2023 Aug; 42(4):589-598. PubMed ID: 37477281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and short-term prognosis of early pulmonary hypertension in preterm infants].
    Wang CH; Chen JJ; Ge JJ; Ma XL; Shi LP
    Zhonghua Er Ke Za Zhi; 2022 Jul; 60(7):682-687. PubMed ID: 35768356
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Medical Treatment of Hemodynamically Significant Patent Ductus Arteriosus on Cerebral and Renal Tissue Oxygenation Measured by Near-Infrared Spectroscopy in Very Low-Birth-Weight Infants.
    Navikienė J; Liubšys A; Viršilas E; Žvirblis T; Jankauskienė A
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?
    Lee JH; Shin JH; Park KH; Rhie YJ; Park MS; Choi BM
    Neonatology; 2013; 103(2):118-22. PubMed ID: 23182972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.